Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-22

Clinical Trial Update: ADA Linagliptin in Long Term Care [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on linagliptin (ADA Linagliptin) in long-term care for diabetes; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linagliptin (linagliptin)

Snippet

Sponsor: Emory University | Conditions: Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2018-08-22